Description
Springer Sickle Cell Anemia From Basic Science to Clinical Practice 1st Editon 2018 Softbound by Fernando Ferreira Costa, Nicola Conran
Although sickle cell anemia was the first molecular disease to be identified, its complex and fascinating pathophysiology is still not fully understood. A single mutation in the beta-globin gene incurs numerous molecular and cellular mechanisms that contribute to the plethora of symptoms associated with the disease. Our knowledge regarding sickle cell disease mechanisms, while still not complete, has broadened considerably over the last decades. Sickle Cell Anemia: From Basic Science to Clinical Practice aims to provide an update on our current understanding of the disease’s pathophysiology and use this information as a basis to discuss its manifestations in childhood and adulthood. Current therapies and prospects for the development of new approaches for the management of the disease are also covered. Chapter 1 Hemoglobin:Structure, Synthesis and Oxygen Transport.- Chapter 2 Sickle cell Anemia: History and Epidemiology.- Chapter 3 Overviewof Sickle Cell Anemia Pathophysiology.- Chapter 4 Red Blood Cells and the Vaso-occlusive Process.- Chapter5 Leukocytes in the vaso-occlusive process.- Chapter 6 Hypercoagulability andSickle Cell Disease.- Chapter 7 Cardiovascular Adaptations to Anemia and theRole of Vascular Endothelium in Sickle Cell Disease Pathophysiology.-Chapter 8Inflammation and Sickle CellAnemia.- Chapter 9 Clinical Manifestations of Sickle Cell Anemia: Infants and Children.-Chapter 10 Treatment of Childhood Sickle Cell Disease.- Chapter 11 Priapism inSickle Cell Disease: New aspects of pathophysiology.- Chapter 12 ClinicalManifestations and Treatment of Adult Sickle Cell.- Chapter 13 Hemoglobin SβThalassemia, SC Disease and SD Disease: Clinical and Laboratorial Aspects.- Chapter 14 Sickle Cell Disease in Africa and the Arabian Peninsula: CurrentManagement and Challenges.- Chapter 15 Genetic Factorsmodifying sickle cell disease severity.- Chapter 16 Future Perspectives for theTreatment of Sickle Cell.